Browse Articles
Discover research articles across all indexed journals
Energy based assessment of submarine landslide tsunamis in the Bay of Naples southern Tyrrhenian Sea
Abstract Submarine mass failures (SMF) represent a potential tsunami source for densely populated coastal areas such as the Bay of Naples (southern Tyrrhenian Sea, Italy). This study applies a three-dimensional numerical modeling framework, combining GEOWAVE/TOPICS and FUNWAVE, to simulate tsunami generation, propagation, and nearshore impact associated with two geomorphologically plausible submarine landslides located at the Dohrn Canyon head and along the Ischia Bank slope. A third configuration considers their combined activation within a deterministic scenario-based approach. The simulations highlight the rapidity of near-field tsunami impact, with waves reaching all monitoring stations (Pozzuoli, Procida, Ischia, Napoli, Sorrento, and Capri) within a few minutes from slide initiation (e.g., arrival times as short as 201 s). The spatial distribution of maximum wave amplitude (MWA) shows significant variability, reflecting the influence of source location, bathymetry, and coastal morphology. In addition to MWA, a cumulative energy indicator (E tot ), obtained by integrating the squared free-surface elevation over time, was evaluated at each virtual gauge. The results indicate that MWA and cumulative energy do not scale linearly. For example, in the combined multi-source scenario, a relatively high MWA of 4.15 m at Ischia (IS) corresponds to a cumulative energy lower than that recorded at other stations characterized by smaller peak amplitudes. This behavior reflects the influence of wave-train duration, local bathymetric effects, and source orientation on energy redistribution. The findings suggest that, while MWA remains the primary parameter for hazard-oriented assessments, cumulative energy provides complementary information on the temporal persistence and overall hydraulic loading of tsunami signals in complex coastal environments.
Low‐Temperature Visual Mechanical Sensing via Uniaxial Compression of Blue Phase Liquid Crystal Elastomer
ABSTRACT Low‐temperature visual mechanical sensing materials hold great promise for applications in cryogenic manufacturing, polar exploration, etc. Blue phase liquid crystals (BPLCs) are a promising candidate for low‐temperature visual sensing materials based on their excellent optical properties and unique chiral helical structure. However, there remain challenges for low‐temperature (<0°C) visual mechanical sensing BPLCs due to difficulties in fabrication of low‐temperature flexible films and inadequate understanding of their thermal–optical–mechanical–structural relationships. Herein, a high‐quality BPLC elastomer (BPLCE) is fabricated via “full chain extension followed by cooling‐assisted assembly” strategy, and it exhibits visual mechanical sensing capabilities across −30 to 60°C based on the synergistic effect of the polymer cross‐linked network (mechanical responsiveness) and BPLC structure (optical signal). There appear high‐ (20°C∼60°C) and low‐sensitivity (−30°C∼20°C) mechanochromic regimes for the as‐prepared BPLCE originating from stress‐induced phase transition of unpolymerized liquid crystals upon cooling, which is validated by temperature‐dependent dramatic change in spectra evolution, stress for equivalent stopband shift, recovery time, etc. Additionally, BPLCE undergoes distinct chiral optical transitions under compression. Potential applications including polarization recognition, critical pressure alert, and in situ low‐temperature full‐field stress monitoring are demonstrated, which may pave a way for advanced visual mechanical sensing in cryogenic engineering.
A Mechanistic Study of Bio‐Based Nanotemplated Carbon Nanofibers Derived From Water Processable Lignin Blends for Sustainable Energy Storage Applications
ABSTRACT This article studies the process for obtaining sustainable and environmentally friendly, carbon nanofibers via an electrospinning process using water without the need for organic solvents or synthetic polymers/binders. Lignosulfonate, gelatin, and alginate are selected for water solubility, ability to produce templated carbon nanostructures and for sustainability. Gelatin and alginate are sacrificial templates during thermal processing, allowing the production of engineered high surface area hollow nanostructures. A mechanistic study is performed to elucidate the relationship between carbon hybridization and electrochemical performance. The as‐spun carbon materials were further characterized for potential applications in sodium‐ion batteries.
Association of higher thermal dose with improved 5-year recurrence-free survival after locoregional hyperthermia combined with intravesical chemotherapy for non-muscle-invasive bladder cancer.
190 Background: To investigate the continuous thermal dose (TD)-effect relationship for estimating the probability of 5-year recurrence-free survival (RFS) in patients with non-muscle-invasive bladder cancer (NMIBC) treated with locoregional chemohyperthermia (CHT). Methods: In this cohort follow-up study (2009−2020; CHIB2; Netherlands Trial Register NL2429), patients with recurrent intermediate- or high-risk NMIBC received 6 weekly sessions of locoregional CHT combined with mitomycin C (MMC), followed by 4 monthly maintenance instillations. Intravesical and perivesical temperatures (urethra, rectum, and, if applicable, vagina) were recorded. Hyperthermia TD was expressed as cumulative equivalent minutes at 43°C (CEM43). Among continuous TD parametrizations, log-transformed Average CEM43T50 was selected using Weibull univariate and stepwise regression analyses, adjusting for recurrence rate, multifocality, and WHO 2004/2016 grade classification. The association between TD and 5-year recurrence risk was additionally evaluated using Fine and Gray competing risks analysis. Results: Sixty patients were included; 83% (n=50) were high-risk and 17% (n=10) intermediate-risk. Thirty patients experienced recurrence after locoregional CHT, with a median time to recurrence of 2.1 years (IQR 0.8−6.5 years). Median Average CEM43T50 was 2.5 minutes, ranging from 0.09−15.2 minutes. Higher TD was significantly associated with increased RFS ( P =<.001). In the Weibull regression, a twofold increase in TD was associated with a 32% decrease in the hazard of recurrence in univariate analysis (95% CI 15%−45%; P =<.001) and a 31% decrease after adjustment (95% CI 12%−45%; P =.002). Fine and Gray analysis confirmed that increasing Average CEM43T50 TD was significantly associated with reduced recurrence risk (unadjusted P =.002; adjusted P =.003). Conclusions: Across the continuous TD range, higher hyperthermia TD (Average CEM43T50) was independently associated with improved 5-year RFS in patients with NMIBC treated with locoregional hyperthermia combined with MMC, showing the paramount importance of achieving high TD in locoregional chemohyperthermia. Clinical trial information: NL2429 .
SGLT-2 inhibitors and heart failure outcomes in cancer patients and survivors: An updated systematic review and meta-analysis.
311 Background: Sodium–glucose cotransporter-2 inhibitors (SGLT-2i) reduce heart failure risk in the general population, but whether that protection extends to cancer patients and survivors is less established. A prior meta-analysis suggested potential benefit; several additional studies have since been published. We performed an updated systematic review and meta-analysis to reassess the association between SGLT-2i use and incident heart failure (HF), HF hospitalization, and all-cause mortality in this population. Methods: We searched PubMed, Embase, the Cochrane Library, and Scopus from inception through 14 January 2026 for studies enrolling cancer patients or survivors that compared SGLT-2i versus non–SGLT-2i control and reported at least one of the three prespecified outcomes. Effect estimates were pooled as risk ratios (RRs) using random-effects and fixed-effect models. Heterogeneity was assessed with I², τ², and Cochran's Q. Robustness was explored through leave-one-out sensitivity analysis and GOSH plots; funnel plots were used to assess small-study effects. Results: Twelve studies were included across outcomes. Incident HF was reported in 4 studies (N=3,073) and was reduced with SGLT-2i (RR 0.39; 95% CI 0.16–0.96; I²=78%). Leave-one-out analysis identified an influential study: omitting Fath 2023 attenuated the estimate to non-significance (RR 0.66; 95% CI 0.41–1.05). GOSH analysis across 15 models showed two distinct clusters — a low-heterogeneity cluster (I²≈0%) centered around RR 0.6–0.7 and a high-heterogeneity cluster (I²=70–90%) centered around RR 0.25–0.4 — consistent with a single influential-study pattern. HF hospitalization was reported in 9 studies (N=9,252) and was lower with SGLT-2i (RR 0.48; 95% CI 0.36–0.66; I²=18.6%). GOSH analysis across 511 models showed the majority of combinations clustering around a protective effect with low-to-moderate heterogeneity, supporting the stability of this estimate. All-cause mortality was reported in 12 studies (N=104,511) and was lower with SGLT-2i (RR 0.47; 95% CI 0.37–0.60), though heterogeneity was very high (I²=98%). GOSH analysis across 4,095 models showed wide dispersion of pooled effects with predominantly high I², though most models remained on the protective side. Conclusions: SGLT-2i use in cancer patients and survivors was associated with lower incident HF, fewer HF hospitalizations, and lower all-cause mortality. The HF hospitalization signal was the most robust, with low heterogeneity and stable pooled estimates across sensitivity analyses. The incident HF result depended substantially on a single study, and the mortality estimate carries little interpretive weight given I²=98%. Prospective studies with prespecified cardio-oncology subgroups are needed before these associations can inform clinical practice.
Regulating π–π Stacking Interactions to Boost Near‐Infrared Light‐Driven CO <sub>2</sub> Reduction
ABSTRACT Developing highly efficient photocatalysts to achieve near‐infrared (NIR) light‐driven CO 2 reduction is of great significance yet remains a great challenge. In this article, we found that BODIPY‐based π frameworks can serve as good NIR photocatalysts, achieving highly efficient CO 2 reduction to HCOO − coupled with benzyl alcohol oxidation to benzaldehyde in pure water. More impressively, the photocatalytic performance of these π frameworks can be improved by regulating π–π stacking interactions, among which the optimized π‐pyrenyl (π‐PY) framework with the most π–π stacking interactions exhibits HCOO − production rates of 4045 and 1693 µmol g −1 h −1 in >99% and 15% CO 2 atmospheres, respectively. π‐PY, thus, stands for the current state‐of‐the‐art photocatalyst in NIR‐light‐driven CO 2 reduction. Experiments together with theoretical calculations demonstrated that the high photocatalytic activity of π‐PY could be due to the abundant π–π stacking interactions, which accelerates charge separation and transfer, as well as prolongs carrier lifetime and reduces energy gap. This work gives new insights in understanding the contribution of π–π stacking interactions to photocatalysis, and introduces a new strategy for developing efficient photocatalysts for NIR‐light‐driven CO 2 reduction.
Palladium(II) complexes suppress biofilm formation and virulence in multidrug-resistant Staphylococcus aureus
Spontaneous Symmetry Breaking via Metal‐Triggered Surface Defect Engineering for Durable Piezocatalytic Hydrogen Evolution
ABSTRACT Piezocatalysis, which converts ubiquitous mechanical energy into chemical fuels, offers a sustainable route for distributed hydrogen production. However, progress in this field has largely been limited to material–level studies, often characterized by weak polarization, insufficient active sites, and a lack of long–term device–level demonstrations. Here, we propose a metal–triggered surface defect strategy that integrates surface metal anchoring with defect formation to simultaneously enhance polarization and increase the density of active sites. Using Au–ZnSnO 3 as a model system, we demonstrate that Au anchoring spontaneously induces Zn vacancy formation, breaking surface symmetry and strengthening the piezoelectric response by more than fivefold. These synergistic effects result in a 3.7‐fold enhancement in the hydrogen evolution rate, placing this material among the top‐performing piezocatalysts. Crucially, integrating the catalyst into a custom‐designed continuous–flow microreactor enables the first demonstration of ultra–long, device–level piezocatalytic hydrogen production for over 158 h, establishing a new benchmark for durability in this field. Experimental and theoretical analyses reveal that Au anchoring reduces the formation energy of Zn vacancies and optimizes hydrogen adsorption energetics, thereby achieving a balance between proton reduction and hydrogen desorption. This work establishes metal–triggered surface defect engineering as a promising design strategy that links structural symmetry with catalytic reactivity in mechanically driven energy conversion systems.
A Self‐Cascading Immunomodulatory Hydrogel for Remodeling Infected Diabetic Wounds
ABSTRACT Methicillin‐resistant Staphylococcus aureus (MRSA)‐infected diabetic foot ulcers (DFUs) remain refractory to healing owing to persistent inflammation, hyperglycemia, and impaired tissue regeneration. Current antimicrobial strategies primarily eliminate viable bacteria but overlook pathogen‐associated molecular patterns (PAMPs) released upon bacterial death, which sustain NF‐κB/NLRP3 activation and prevent immune resolution. However, suppressing microbial burden without neutralizing PAMP‐driven inflammation fails to restore the regenerative wound microenvironment. Here, we report a self‐cascading hypoglycemic immunomodulatory hydrogel integrating Fe 3 O 4 @Au nanozymes with phenylboronic acid‐modified hyaluronic acid and dopamine‐functionalized silk fibroin. The platform exploits endogenous glucose to drive cascade catalysis for efficient MRSA eradication (∼99.99% with near‐infrared assistance), while dynamically exposing catechol and boronic acid motifs to sequester PAMPs and suppress inflammatory signaling. Consequently, macrophages are reprogrammed from pro‐inflammatory M1 to pro‐healing M2 phenotypes, enabling immune microenvironment remodeling. In MRSA‐infected DFU models, this coordinated antibacterial‐immunomodulatory strategy markedly accelerates wound closure, leaving only ∼13.97% residual area after 14 days. These results establish a design paradigm that couples biocatalysis with immune regulation for treating complex infected wounds.
Axillary lymph node metastasis status and associated factors in patients with breast cancer undergoing radical surgery.
63 Background: Breast cancer remains one of the most frequently diagnosed malignancies and a leading cause of cancer-related mortality worldwide. According to GLOBOCAN 2022, it ranks second in incidence with more than 2.2 million new cases, following lung cancer, and fourth in global cancer mortality. Lymphatic dissemination represents the principal pathway of metastasis in breast cancer; therefore, accurate assessment of axillary lymph node status is essential for staging, prognostication, and therapeutic decision-making. Currently, nodal metastasis is primarily diagnosed based on routine hematoxylin and eosin (H&E) staining. However, accumulating evidence indicates that certain metastatic deposits, particularly micrometastases, may be overlooked when evaluated solely by conventional H&E staining. The application of immunohistochemistry (IHC) has enhanced the detection of these occult nodal micrometastases. To date, no study has investigated the characteristics of axillary lymph node micrometastasis in breast cancer patients at our institution. Objective: This study aimed to describe the characteristics of axillary lymph node micrometastasis detected by immunohistochemistry but not identified by routine H&E staining, and to explore associated clinicopathological factors in breast cancer patients undergoing radical surgery. Methods: A retrospective descriptive study was conducted on 56 breast cancer patients with stage pT any/N0M0 who underwent radical surgery at Hanoi Medical University Hospital between January 2021 and August 2025. Results: IHC staining identified lymph node micrometastases in 4 out of 56 patients (7.14%). No statistically significant associations were found between micrometastases and estrogen receptor, progesterone receptor, HER2 status, Ki67 index, vascular invasion, perineural invasion, or tumor size. Among the 4 patients with micrometastases, 3 received additional adjuvant radiotherapy following the detection by IHC. Conclusions: The rate of lymph node micrometastases detected by IHC in this study was 7.14%. Immunohistochemical staining improves the detection of micrometastases compared to conventional HE staining, and may influence adjuvant treatment strategies in breast cancer patients.
Bayesian multimodal modeling with explainable artificial intelligence to predict response to GBE1-targeted metabolic therapy in colorectal cancer.
9 Background: Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, with therapeutic resistance limiting durable clinical benefit. Metabolic reprogramming is an important yet incompletely understood driver of tumor progression, enabling CRC cells to adapt to metabolic stress and shape an immunosuppressive tumor microenvironment. Our prior work identified glycogen metabolism, including GBE1-driven pathways, as a key regulator of CRC metabolic and treatment response. We integrate multimodal data with explainable artificial intelligence to model metabolic heterogeneity and improve prediction of therapeutic effectiveness while preserving biological interpretability. Methods: Multimodal datasets were integrated, including genomics, transcriptomics, CMS subtypes, histopathology-derived features, and clinical outcomes from TCGA-COAD, CRC-SG, AACR BPC CRC v2.0, and institutional cohorts. Genotyping data were processed through the variant-calling pipeline, and pseudo-bulk expression profiles were performed and visualized across 629 available samples. Clinical and molecular variables were harmonized to construct a framework for estimation. NetraAI, an explainable artificial intelligence platform employing an iterative machine learning strategy, was applied to identify treatment-responsive patient subpopulations. Predictive modeling combined ensemble learning and penalized regression approaches to generate interpretable feature attribution metrics (SHAP values). Model outputs were further incorporated into a Bayesian inference framework to enable probabilistic outcome prediction while accounting for prior data. Model performance was evaluated using stratified cross-validation, ROC analysis, and Bayesian credible intervals. Results: Multimodal modeling identified six key features associated with response to GBE1 inhibition, including glycogen content, GBE1 expression, CMS subtype, and lipid metabolic gene signatures. SHAP analyses ranked glycogen content (6.2), GBE1 expression (3.92), and CMS4 subtype (0.35) as dominant predictors. Bayesian integration improved predictive performance compared by validation cohorts (AUC 0.81 vs 0.61). Explainability analyses highlighted glycogen and lipid metabolism, hypoxia, and immune features as key drivers of response. Synthetic multimodal data preserved biologically plausible relationships and enhanced model generalizability across molecular subtypes and treatment contexts. Conclusions: Integration of multimodal CRC data with explainable AI enables accurate and interpretable prediction of response to GBE1-targeted metabolic therapy. This framework supports the high dimensional analysis and metabolic reprogramming as a clinically actionable vulnerability and advancing precision metabolic therapy in CRC.
Defect-Mediated Catalysis for Low-Temperature Formation of Graphene-Based Materials
Correction to “Thermally‐Stable Single‐Site Pd on CeO <sub>2</sub> Catalyst for Selective Amination of Phenols to Aromatic Amines Without External Hydrogen”
An AI-enabled federated blockchain framework for adaptive energy coordination in smart electric mobility networks
Mechanically Robust Ceramic Aerogels for Radiative Cooling and Thermal Insulation
ABSTRACT Cooling and heating consume about half of global energy and result in various environmental problems. Radiative cooling and thermal insulation can reduce energy consumption, yet the existing materials that integrate both properties have limitations in working temperature range and mechanical robustness. Herein, we report a flexible and ultralow‐density HfO 2 ‐ZrO 2 ‐SiO 2 ceramic aerogel fabricated via a modified electrospinning method, which synergistically integrates radiative cooling, thermal insulation, mechanical robustness, and an ultrawide temperature range. It achieves high solar reflectance (98.0%) and high infrared emittance (98.4%) for daytime radiative cooling, along with ultralow thermal conductivity (24.7 mW m −1 K −1 at 2.58 mg cm −3 ), enabling 24‐hour thermal insulation. It also exhibits excellent mechanical properties at 7.50 mg cm −3 , including 245 kPa tensile strength, 1.47 MPa compressive strength, and 182 kPa bending strength, along with an ultrawide working temperature range from −196°C to 1300°C. Moreover, in lunar environment simulation experiments, our aerogel achieves ∼50.0°C cooling below ambient during the day and ∼37.5°C thermal retention above ambient at night, successfully maintaining electronics above −16.7°C in an ambient temperature of −183°C. This work provides a mechanically robust ceramic aerogel solution for low‐energy consumption, 24‐hour thermal management in aerospace, deep‐space exploration, and high‐precision instruments.
Compartmentalized Porosity in a Hydrogen‐Bonded Organic Framework Enables High‐Capacity C <sub>3</sub> H <sub>6</sub> /C <sub>2</sub> H <sub>4</sub> Separation
ABSTRACT Hydrogen‐bonded organic frameworks (HOFs) are promising adsorbents for gas separation, yet capacity breakthroughs are frequently limited by a pore‐architecture trade‐off in which increased pore volume is accompanied by cavity expansion and weakened confinement. Herein, we report HOF‐BUT‐1, constructed from an unprecedented 8‐connected linker, resulting in compartmentalized porosity. This HOF thus combines high porosity (pore volume = 0.95 cm 3 /g) with a small largest cavity diameter of 7.6 Å. Enabled by its balanced pore structure, HOF‐BUT‐1 exhibits a record‐high propylene uptake of 8.83 mmol/g at 298 K and 1 bar, and thereby the highest separation potential (Δ Q ) of 6.45 mmol/g for equimolar C 3 H 6 /C 2 H 4 mixture among reported HOFs. Dynamic breakthrough experiments can deliver polymer‐grade C 2 H 4 (≥99.95%) and C 3 H 6 (≥99.5%) with productivities of 4.79 and 2.88 mmol/g, respectively, and maintain performance over repeated cycles, demonstrating high potential for methanol‐to‐olefins products upgrading.
B7H3/IL13Rα2 bispecific armored CAR-T for recurrent/refractory glioblastoma: Safety, efficacy, and immune dynamics.
69 Background: Recurrent/refractory glioblastoma (GBM) has an extremely poor prognosis with limited therapies. CAR-T therapy is innovative but hindered by antigen escape and insufficient durability; unclear early CAR-T trafficking/adaptation also limits its efficacy. We developed a fully human bispecific armored CAR-T targeting B7H3/IL13Rα2 with PK-guided multiple infusions and explored immune dynamics via single-cell multi-omics+TCR-seq. Methods: This 3+3 dose-escalation study (2.5, 5.0, 10, 20 million cells) enrolled 18-75-year-old recurrent/refractory GBM patients with ≥30% B7H3/IL13Rα2 expression (IHC). Patients received intracavity/intraventricular infusions via Ommaya catheter (PK monitoring guided dosing). Single-cell transcriptome+TCR-seq was performed on infused CAR-T and day-3 tumor cavity CSF to analyze immune dynamics. The primary objective was safety, and the secondary objectives were efficacy and the exploration of immune dynamics. Results: Two IDH-wildtype, MGMT-unmethylated patients completed 2.5 million-cell infusions, with no dose-limiting toxicities (DLTs) observed. Adverse events including fatigue, thrombocytopenia, abnormal liver function, and hypoalbuminemia were manageable without ICU admission, and the maximum grade of cytokine release syndrome (CRS) was 1, which resolved spontaneously within 3-5 days. Abundant central memory T cells and persistent high CAR-T copy numbers (≥3 weeks) were detected in the CSF, and per RANO2.0 criteria, the best overall responses were ≥30% tumor reduction in one patient (with 3-month progression-free survival) and stable disease (SD) in the second patient. Single-cell+TCR-seq showed infused CAR-T was predominantly CD8⁺/CD4⁺ T cells with heterogeneous phenotypes. Day-3 CSF had diverse immune populations; GSVA showed memory enrichment without dominant exhaustion. TCR-seq identified 188 infused-derived CAR-T cells (2.19% homing rate), mainly from cytotoxic/proliferating CD8⁺ and effector CD4⁺ T cells. Cytotoxic CD8⁺ T cells clonally expanded; proliferating CD8⁺ shifted to cytotoxic states; activated CD4⁺ transitioned to memory-like phenotypes. CSF CAR-T had stronger memory signatures (GSVA, p=2.48×10⁻⁹). Conclusions: B7H3/IL13Rα2 bispecific CAR-T with PK-guided low-dose infusions has favorable safety and preliminary efficacy in recurrent/refractory GBM, with robust CAR-T expansion/persistence. Single-cell analyses characterize immune dynamics, providing mechanistic insights for CAR-T optimization in solid tumors. Clinical trial information: NCT07193628 .
Biomarker-independent real-world effectiveness and safety of toripalimab in advanced esophageal squamous cell carcinoma: A multicentre Indian experience.
131 Background: Toripalimab has demonstrated survival benefit in advanced esophageal squamous cell carcinoma (ESCC) in randomized trials. However, real-world data from India, particularly in patients with low or undocumented PD-L1 expression, remain limited. We evaluated the real-world effectiveness and safety of toripalimab in advanced ESCC across multiple tertiary care centres in India. Methods: This retrospective multicentre study reviewed electronic medical records of adults with advanced or metastatic ESCC treated with toripalimab between February 2025 and January 2026. Outcomes included objective response rate (ORR), disease control rate (DCR), real-world progression-free survival (rwPFS), and treatment-related adverse events. Subgroup analyses were performed by line of therapy and PD-L1 status. Results: Thirty-one patients were identified, of whom 30 were evaluable for efficacy (median age 59 years; 54.8% female). Most patients had ECOG performance status 0-1 (70.9%) and visceral metastases (74.2%). Toripalimab was administered in the first line setting in 54.8%. The ORR was 60.7% and DCR was 67.9%, with higher ORR in first-line therapy compared with later lines (68.9% vs 50%). Responses were observed across PD-L1 subgroups, including patients with PD-L1 <1% and those without PD-L1 testing. Median rwPFS was 6.1 months (95% CI 4.5-NR) for the cohort. Key clinical outcomes summarized in Table 1. Treatment-related adverse events were consistent with the known safety profile of PD-1 inhibitors, with no treatment discontinuations due to toxicity. Conclusions: In this multicentre Indian real-world cohort, toripalimab demonstrated clinically meaningful activity with manageable toxicity in advanced ESCC, including in patients with low or undocumented PD-L1 expression. These findings provide supportive real-world evidence of toripalimab activity across PD-L1 subgroups in routine clinical practice. Key clinical outcomes. Endpoint Overall(n=30) PD-L1 ≥1%(n=19) PD-L1 <1%/not done/unknown(n=11) ORR 60.7% 52.6% 77.8% DCR 67.9% 63.2% 77.8% Median rwPFS (months) 6.1 7.7 6
Enhancement of red lettuce growth and photosynthesis through the use of coherent-structure and hybrid water sources supplemented with sodium selenate
Unveiling the Key to Spent LiFePO <sub>4</sub> Regeneration: Formation and Action of Carbon Dots
ABSTRACT Introducing organic molecules to repair structure defects through hydrothermal treatment has emerged as a promising strategy for the direct regeneration of spent LiFePO 4 (SLFP). Here, we find a universal rule that abundant carbon dots (CDs) are generated from various organic molecules during the direct regeneration process, playing a key role in the regeneration of SLFP. By employing purified CDs to regenerate SLFP, we demonstrated that CDs can not only manifest a reduction effect during the hydrothermal process but also reconstruct the uneven carbon layer in the subsequent sintering stage. As expected, excellent electrochemical performances are exhibited by the regenerated LiFePO 4 (RLFP), delivering a high discharge specific capacity of 140.1 mAh g −1 at a 1 C rate and maintaining a capacity retention rate of 91% after 1000 long‐term cycles. After systematically analyzing the structure and electrochemical performance of LiFePO 4 (LFP) regenerated with CDs and their corresponding precursors, we propose the selection principle of organic molecules in the regeneration process of SLFP: organic molecules prone to form CDs under the hydrothermal condition are the most suitable for the regeneration of SLFP. This work offers important insights into the regeneration mechanisms of LFP and provides key guidelines for the selection of reducing agents.